Nomura Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-26,139
Closed -$544K 1562
2023
Q2
$849K Hold
26,139
﹤0.01% 817
2023
Q1
$1.02M Hold
26,139
0.01% 795
2022
Q4
$1.38M Hold
26,139
0.01% 758
2022
Q3
$1.18M Hold
26,139
0.01% 773
2022
Q2
$951K Buy
26,139
+5,252
+25% +$191K 0.01% 821
2022
Q1
$862K Buy
20,887
+2,293
+12% +$80.7K ﹤0.01% 854
2021
Q4
$792K Hold
18,594
﹤0.01% 874
2021
Q3
$1.02M Hold
18,594
0.01% 815
2021
Q2
$890K Sell
18,594
-1,400
-7% -$71.3K 0.01% 861
2021
Q1
$1.01M Buy
+19,994
New +$1.11M 0.01% 831

Other funds holding SILK

Nomura Asset Management's SILK Position: Q3 2023 in Review

Nomura Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 26,139 shares — an estimated $544K sold.

Nomura Asset Management first reported a position in SILK in Q1 2021 and held it in 10 quarters. The position peaked at $1.38M in Q4 2022. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Nomura Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nomura Asset Management sold 26,139 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $544K.
  • Nomura Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Nomura Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $1.38M in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Nomura Asset Management's 13F filing for Q3 2023, filed 3 Nov 2023.